Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 102 of 102 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/08/22
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 08/16/18
End: 06/07/24
Due: 06/07/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A PhaseⅠStudy of HS-10381 in Patients With Advanced Solid Tumors | NCT05378178 | Jiangsu Hansoh Pharmaceutical Co., Ltd. | user2@example.com | None | 2022-06-08 | 2024-12-31 | 2025-12-31 | - | - | 2025-07-14 |
| Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection | NCT03903796 | Jiangsu Hansoh Pharmaceutical Co., Ltd. | user2@example.com | None | 2018-08-16 | 2024-06-07 | 2025-06-07 | - | - | 2025-07-14 |